Companies/Pharma-Bio Serv, Inc.

Company profile

Pharma-Bio Serv, Inc.

OTC: PBSV · Healthcare · Medical - Healthcare Information Services

PublicHQ Dorado, PRCIK 0001304161Reports USD

#641 of 1,394 Healthcare companies by revenue35th-percentile growth

EA Score

58C

FH 77DQ 37GM 45SS 60

v0.1 · 65/100 weight · provisional

↑ balance-sheet leverage, return on assets · ↓ filing timeliness, 3-yr revenue growth

Methodology →

Revenue TTM

$9.1M

Rev growth YoY (TTM)

-5.5%

Net income (FY)

-$100.5k

Employees

Market cap

$13.1M

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Revenue$9.0M$9.0M2025

Net income-$100.5k-$100.5k2025

Operating income-$637.7k-$637.7k2025

Total assets$13.7M$13.7M2025

Liabilities$1.7M$1.7M2025

Equity$11.9M$11.9M2025

Revenue trend

FY2018 – FY2025 · USD

$17.8M

FY18

$19.5M

FY19

$21.6M

FY20

$20.1M

FY21

$19.4M

FY22

$17.0M

FY23

$9.5M

FY24

$9.0M

FY25

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

Pharma-Bio Serv, Inc. booked $9.0M in FY2025 revenue, contracting 5.3% year over year — slower than 65% of Healthcare companies we track, at a -1.1% net margin.

Peers · Healthcare

Aurora Spine Corporation65B Vyome Holdings, Inc.33D Biofrontera Inc.46D Bionano Genomics, Inc.47D

Key facts

CEOVictor Sanchez

SectorHealthcare

IndustryMedical - Healthcare Information Services

HeadquartersDorado, PR

ExchangeOTC: PBSV

Employees75

IPO date2007-05-07

Latest filings

10-Q2026-06-15 8-K2026-06-15 8-K2026-05-15 DEF 14A2026-04-16 8-K2026-03-17 10-Q2026-03-17 10-K2026-01-29 8-K2026-01-29

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.